Concepedia

Author

Yuanfei Shi

First Affiliated Hospital of Xiamen UniversityORCID

Also Known As

Shi, Yuanfei, Y.Y. Shi, Yuan-Fei Shi, Yuanfei Shi, Yuan‑Fei Shi

53

Publications

738

Citations

13

H-Index

11

Concepts

All Affiliations

First Affiliated Hospital of Xiamen UniversityXiamen UniversityFujian Medical UniversityZhejiang UniversityFirst Affiliated Hospital Zhejiang University
YS

About

Yuanfei Shi is an author at First Affiliated Hospital of Xiamen University specializing in tumor biology, cell biology, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

38

2

Cell Biology

2

2

38

3

Immunology

1

1

14

4

Pathology

1

1

24

5

Cell Signaling

1

1

14

Yuanfei Shi

×

13

Publications

275

Citations

12

H-Index

YearCitations

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair

Jing Ye, Jie Zha, Yuanfei Shi,

Clinical Epigenetics

2019

59

Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway

Yuanfei Shi, Long Liu, Lingli He,

Cell Death and Disease

2020

30

The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia

Yuanfei Shi, Jing Ye, Ying Yang,

Frontiers in Oncology

2021

27

Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia

Manman Deng, Jie Zha, Zhiwu Jiang,

Journal of Translational Medicine

2018

26

Apatinib exhibits cytotoxicity toward leukemia cells by targeting VEGFR2-mediated prosurvival signaling and angiogenesis

Manman Deng, Jie Zha, Haijun Zhao,

Experimental Cell Research

2020

24

The diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patients

Huafei Shen, Yanchun Zhao, Yuanfei Shi,

Hematology

2020

16

Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas

Yan Zhang, Yanlong Zheng, Lihong Shou,

Frontiers in Oncology

2020

16

CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models

Manman Deng, Haijun Zhao, Qinwei Chen,

European Journal of Pharmacology

2019

14

The prognostic value of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the treatment response and survival of patients with peripheral T-cell lymphoma

Yanchun Zhao, Yuanfei Shi, Huafei Shen,

Leukemia & lymphoma/Leukemia and lymphoma

2019

14

Low‐dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo

Yuanfei Shi, Haijun Zhao, Jing Ye,

Molecular Carcinogenesis

2020

13

Page 1